Antiproliferative activity and phototoxicity of some methyl derivatives of 5-methoxypsoralen and 5-methoxyangelicin

Pharmacology and Toxicology

Volumn 82, Issue 4, 1998, Pages 193-198

  Conconi, Maria Teresa ^a   Montesi, Francesco ^b   Parnigotto, Pier P ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Experimental Zooprophylactic Institute of Venice   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3,4' DIMETHYL 5 METHOXYANGELICIN; 3,4' DIMETHYL 5 METHOXYPSORALEN; 4,4' DIMETHYL 5 METHOXYANGELICIN; 4,4' DIMETHYL 5 METHOXYPSORALEN; 5 METHYLANGELICIN; BERGAPTEN; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CELL STRAIN HL 60; CELL ULTRASTRUCTURE; COCULTURE; CYTOPATHOGENIC EFFECT; DRUG EFFECT; GROWTH INHIBITION; HUMAN; HUMAN CELL; PHOTOTOXICITY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

CAVIA PORCELLUS; SUS SCROFA;

EID: 0031955732     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1998.tb01424.x     Document Type: Article

References (26)

1. Aubin, F., S. Makki, P. Humbert, P. Muret & P. Agache: Treatment of psoriasis with a new micronized 5-methoxypsoralen tablet and UVA radiation. Arch. Dermatol. Res. 1994, 286, 30-34.
2. Ben-Hur, E. & P. S. Song: The photochemistry and photobiology of furocoumarins (psoralens). Adv. Radiat. Biol. 1984, 11, 131-171.
3. Berg, M. & A. M. Ros: Treatment of psoriasis with psoralens and ultraviolet A. A double-blind comparison of 8-methoxypsoralen and 5-methoxypsoralen. Photodermatol. Photoimmunol. Photomed. 1994, 10, 217-20.
4. Botham, P. A., D. A. Basketter, T. Maurer, D. Mueller, M. Potokar & W. J. Bontinck: Skin sensitization A critical review of predictive test methods in animals and man. Fd. Chem. Toxic. 1991, 4, 275-286.
5. Calzavara-Pinton, P., B. Ortel, A. Carlino, H. Honigsmann & G. De Panfilis: A reappraisal of the use of 5-methoxypsoralen in the therapy of psoriasis. Exp. Dermatol. 1992, 1, 46-51.
6. Conconi, M. T., P. P. Parnigotto, A. Bonali & G. Zagotto: Inhibition of growth, morphological and morphometrical changes induced by amido-anthraquinone derivatives in NCTC2544 and HeLa cells. ATLA 1992, 20, 84-94.
7. Conconi, M. T., F. Valenti, F. Montesi, V. Bassani, S. De Angeli & P. P. Parnigotto: Effects of benzopsoralen derivatives on HL60 and HeLa cells. Pharmacology & Toxicology 1996, 79, 340-346.
8. Daniels, F., D. Brophy & W. C. Lobitz: Histochemical responses of human skin following ultraviolet irradiation. J. Invest. Dermatol. 1961, 37, 351-357.
9. Gia, O., A. Anselmo, M. T. Conconi, C. Antonello, E. Uriarte & S. Caffieri: 4′-methyl derivatives of 5-MOP and 5-MOA: synthesis, photoreactivity, and photobiological activity. J. Med. Chem. 1996, 22, 4489-4496.
10. Guiotto, A., P. Rodighiero, P. Manzini, G. Pastorini, F. Bordin, F. Baccichetti, F. Carlassare, D. Vedaldi, F. Dall' Acqua, M. Tamaro, G. Recchia & M. Cristofolini: 6-Methylangelicins: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. J. Med. Chem. 1984, 27, 959-967.
11. 2 (rat kangaroo cells). Cancer Res. 1985, 45, 717-725.
12. Lerman, S.: Psoralens and ocular effects in man and animals: in vivo monitoring of human ocular and cutaneous manifestations. Natl. Cancer. Inst. Monogr. 1984, 66, 227-233.
13. Loveday, K. S.: Interrelationship of photocarcinogenicity, photomutagenicily and phototoxicity. Photochem. Photobiol. 1996, 63, 369-372.
14. Malorni, W., F. Iosi, F. Mirabelli & G. Bellomo: Cytoskeleton is a target in menadione-induced oxidative stress in cultured mammalian cells: alterations underlying surface bleb formation. Chem. Biol. Interactions 1991, 80, 217-236.
15. Malorni, W., G. Donell, E. Straface, M. T. Santini, S. Paradisi & P. U. Giacomoni: Both UVA and UVB induce cytoskeleton-dependent surface blebbing in epidermoid cells. J. Photochem. Photobiol. B: Biol. 1994, 26, 265-270.
16. Meyer, K., J. Schwartz, D. Crater & D. Keyes: Zingiber officinale (ginger) used to prevent 8-MOP associated nausea. Dermatol. Nurs. 1995, 7, 242-244.
17. Musajo, L. & G. Rodighiero: Mode of photosensitizing action of furocoumarins. In: Photophysiology vol. VII. Academic Press, New York, 1972, 115-147.
18. Ortel, B. & R. W. Gange: An action spectrum for the elicitation of erythema in skin persistently sensitized by photobound 8-methoxypsoralen. J. Invest. Dermatol. 1990, 94, 781-785.
19. Palumbo, M., F. Baccichetti, C. Antonello, O. Gia, A. Capozzi & S. Murciani Magno: Photobiological activity of 3,4′-dimethyl-8-methoxypsoralen, a linear furocoumarin with unusual DNA-binding properties. Photochem. Photobiol. 1990, 52, 533-540.
20. Robinson, M. K., E. R. Fletcher, G. R. Johnson, W. E. Wyder & T. Maurer: Value of the cutaneous basophil hypersensitivity (CBH) response for distinguishing weak contact sensitisation from irritation reactions in the guinea skin. J. Invest. Dermatol. 1990, 94, 636-643.
21. Rodighiero, G. & C. Antonello: Sintesi dell' isobergaptene. Il Farmaco 1955, 10, 3-10.
22. Song, P. S. & K. S. Tapley: Photochemistry and photobiology of psoralens. Photochem. Photobiol. 1978, 29, 1177-1197.
23. Stern, R. S., K. T. Nichols & L. H. Vakeva: Malignant melanoma in patients treated for psoriasis with methoxalen (psoralen) and ultraviolet A radiation (PUVA). New Engl. J. Med. 1997, 336, 1041-1045.
24. Tanew, A., B. Ortel, K. Rappersberger & H. Honigsmann: 5-methoxypsoralen (Bergapten) for photoehemotherapy. Bioavailability, phototoxicity and clinical efficacy in psoriasis of a new drug preparation. J. Amer. Acad. Dermatol. 1988, 18, 333-338.
25. Wilgram, G. F., R. L. Kidd, W. S. Krawczyk & P. L. Cole: Sunburn effect on keratinosomes. Arch. Dermatol. 1970, 101, 505-519.
26. Wolff, K. & H. Honigsmann: Safety and therapeutic effectiveness of selected psoralens in psoriasis. Natl. Cancer. Inst. Monogr. 1984, 66, 159-164.